State Street Corp C4 Therapeutics, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 2,806,913 shares of CCCC stock, worth $11.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,806,913

Previous 2,994,948 6.28%

Holding current value

$11.4 Million

Previous $13.8 Million 15.63%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$4.43 - $7.38 $832,995 - $1.39 Million	-188,035 Reduced 6.28%	2,806,913 $16 Million
Q2 2024 Aug 14, 2024	SELL	$4.05 - $8.1 $16.8 Million - $33.7 Million	-4,158,332 Reduced 58.13%	2,994,948 $13.8 Million
Q1 2024 May 15, 2024	BUY	$5.3 - $11.0 $37.1 Million - $77 Million	6,997,907 Added 4503.94%	7,153,280 $58.4 Million
Q2 2023 Aug 14, 2023	SELL	$2.75 - $3.77 $1.7 Million - $2.33 Million	-618,848 Reduced 79.93%	155,373 $427,000
Q1 2023 May 15, 2023	SELL	$3.1 - $9.02 $5.19 Million - $15.1 Million	-1,673,376 Reduced 68.37%	774,221 $2.43 Million
Q4 2022 Feb 14, 2023	BUY	$5.42 - $10.24 $2.63 Million - $4.97 Million	485,785 Added 24.76%	2,447,597 $14.4 Million
Q3 2022 Nov 15, 2022	BUY	$8.03 - $12.77 $10 Million - $15.9 Million	1,245,369 Added 173.83%	1,961,812 $17.2 Million
Q2 2022 Aug 15, 2022	SELL	$5.06 - $26.46 $7.65 Million - $40 Million	-1,511,316 Reduced 67.84%	716,443 $5.4 Million
Q1 2022 May 16, 2022	BUY	$19.99 - $33.23 $12.8 Million - $21.2 Million	638,006 Added 40.13%	2,227,759 $54 Million
Q4 2021 Feb 14, 2022	SELL	$29.39 - $46.86 $2.02 Million - $3.23 Million	-68,877 Reduced 4.15%	1,589,753 $51.2 Million
Q3 2021 Nov 15, 2021	BUY	$35.91 - $50.5 $10.3 Million - $14.5 Million	288,008 Added 21.01%	1,658,630 $74.1 Million
Q2 2021 Aug 16, 2021	BUY	$30.39 - $42.18 $15.4 Million - $21.4 Million	507,389 Added 58.78%	1,370,622 $51.9 Million
Q1 2021 May 17, 2021	BUY	$31.96 - $46.5 $22.3 Million - $32.5 Million	698,102 Added 422.76%	863,233 $31.9 Million
Q4 2020 Feb 16, 2021	BUY	$22.8 - $37.05 $3.76 Million - $6.12 Million	165,131 New	165,131 $5.47 Million

Others Institutions Holding CCCC

# of Institutions

130

Shares Held

63.5M

Call Options Held

670K

Put Options Held

54.8K

View Full List

About C4 Therapeutics, Inc.

Ticker CCCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,913,800
Market Cap $198M
Description
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...

More about CCCC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp C4 Therapeutics, Inc. Transaction History